Opendata, web and dolomites

Vitreoject

Disrupting Medical Instruments for Eye Care.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Vitreoject project word cloud

Explore the words cloud of the Vitreoject project. It provides you a very rough idea of what is the project "Vitreoject" about.

validated    unchanged    drug    age    million    2017    remained    manufactured    filed    ug    elderly    game    sterilisation    injections    strategy    2018    transformative    experimental    dabous    prototype    device    viability    operations    localised    financial    worldwide    visual    material    sme1    administered    2004    team    original    eye    impairment    liability    patent    medication    macular    efficient    functional    injection    risk    group    care    leaders    saving    formulated    economy    ophthalmologists    compromising    april    invention    vitreoject    injected    mostly    disruptive    disburden    249    setting    strive    global    health    theatre    degeneration    integration    changing    move    annually    adoption    founded    dr    healthcare    rose    unpredictability    lack    feasibility    industry    market    safer    disrupt    reducing    ophthalmology    medical    save    kromer    yearly    parts    optimising    hamburg    time    2019    contains    instruments    mr    commercial    limited    solution    mio    introduction   

Project "Vitreoject" data sheet

The following table provides information about the project.

Coordinator
VITREOJECT UG (HAFTUNGSBESCHRANKT) 

Organization address
address: HANS-HENNY-JAHNN-WEG 7
city: HAMBURG
postcode: 22085
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.vitreoject.de
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VITREOJECT UG (HAFTUNGSBESCHRANKT) DE (HAMBURG) coordinator 50˙000.00

Map

 Project objective

Dr Kromer and Mr Dabous founded Vitreoject UG (limited liability) in Hamburg in 2018. Together with our team, we aim to increase access to eye care by improving and optimising process operations. Age-related macular degeneration is the leading cause of visual impairment in the elderly and treated with medication injected into the eye. Before the introduction of the drug, less than 5,000 injections were administered annually. Since then, global numbers rose to more than 90 million worldwide. However, there is a lack of an optimised approach as the injection process has mostly remained unchanged since 2004. With the Vitreoject device, we strive to disrupt the process of these injections by compromising all needed parts into one device, making it more efficient, material-saving and above all, safer. Vitreoject is the only device that allows the game-changing localised sterilisation and integration of all steps into one device. We develop the transformative invention with support from industry leaders from the ophthalmology and economy sector, as well as a leading group of ophthalmologists. Our device has the potential to save € 249 Mio yearly in health care costs in Europe by reducing operating theatre time. The medical device market is a high risk market due to the unpredictability of the product adoption. This SME1 proposal contains a feasibility study on the technical aspects of the product, the commercial strategy, implementation and its financial viability. The original technology concept was formulated in late 2017, and a patent filed in April 2018. The solution is now developed as a functional working prototype that has been validated in an experimental setting, and we would like to use this SME1 feasibility study to be able to advance and move forward to a manufactured product in late 2019. Vitreoject is dedicated to developing disruptive medical instruments for eye care which will be able to disburden the European Healthcare system.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VITREOJECT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VITREOJECT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More  

Path Feel (2019)

Insoles for Neuropathy and Balance Issues

Read More